Shenji Bio
Nanjing
About Shenji Bio
Shenji Bio focuses on the research and development of fundamental raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies. As a development direction, Shenji Bio provides cost-effective products and addresses clinical unmet needs. It has gradually entered the upstream core raw material fields of IVD, mRNA, CGT, and other industries, and has established a high-quality key common technology platform to provide overall solutions for the life science field's development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $47.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2025)
- Website: syngenebio.com
- Phone: 025-8369-6681
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/shenji-bio-11425 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.